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ABSTRACT 
Basophils are circulating granulocytes. They are very rare and represent less than 1% of 
peripheral blood leukocytes. Basophils connect the innate and adaptive immune responses by 
the secretion of a variety of immune-mediators involved in the pathogenesis of many 
inflammatory diseases mainly allergic reactions and autoimmune diseases. For many years it 
was difficult to study basophil function due to their rareness in peripheral blood which 
resulted in scant yields and purity when isolated. This thesis focuses on studies of the 
basophil function in two inflammation-driven diseases: chronic kidney disease (CKD) and 
allergy. The investigations have been done using newly developed microfluidic-based lab-on-
chip technology and conventional immunological methods. In paper I, we investigated the 
impact of blood-membrane interaction on circulating basophils and neutrophils in 
hemodialysis patients (stage 5D), using high-flux and low-flux dialyzers. Passage through the 
low-flux dialyzer, as opposed to high-flux, induced a significant upregulation of CD63 on 
formyl-methyinoyl-leucyl-phenylalanine (fMLP) and anti-FcεRI antibody stimulated 
basophils. Furthermore, (fMLP) stimulated basophils significantly upregulated CD63, in 
patients compared to healthy controls. There were no significant differences in the expression 
of neutrophil activation markers (CD11b, the active epitope of CD11b, and CD88), when 
comparing the two dialyzers, or when compared to healthy controls. In paper II, we analyzed 
the expression of activator markers on basophils related to two crucial functions 
(transmigration and degranulation) in CKD (stage 5D). The CD300a expression was 
significantly higher in patients following activation by fMLP and anti-FcɛRI-ab and the 
expression of the active epitope of CD11b was significantly higher in patients after 
lipopolysaccharide (LPS) activation. The CD62L expression was significantly downregulated 
in anti-FcɛRI activated basophils from healthy controls. In paper III, we developed a novel 
microfluidic immuno-affinity based basophil activation test (miBAT) assay. The microfluidic 
device is capable of isolating basophils directly from whole blood and we analyzed the 
regulation of CD203c and CD63 in anti-FcεRI activated basophils in healthy and allergic 
individuals. The microfluidic chip was able to capture basophils from whole blood with an 
efficiency of 65% and the CD63 expression detected via fluorescent microscope was 
significantly higher in activated basophils compared to non-activated basophils (negative 
control), as well as in allergic patients compared to healthy controls in microfluidic chip. The 
result was comparable to flow cytometry data. In paper IV we validated that the miBAT 
platform can be used for allergy diagnosis. CD63 expression on basophils activated with 
allergens was detected in microfluidic chip and flow cytometry. The activation was 
significantly higher compared to non-activated basophils in allergic patients. Basophils from 
non-allergic individuals did not respond to allergen activation. The microfluidic chip analysis 
was comparable with flow cytometry data. 
In conclusion, this thesis presents new insights on the role of basophils in the inflammatory 
responses, mainly related to innate immune responses in CKD patients. Moreover, we 
introduced a novel microfluidics based method (miBAT) to quantify basophil activation in 
allergic patients. The method has great potential to be used as a point of care for allergy 
diagnosis. 
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1 INTRODUCTION 
1.1 IMMUNE SYSTEM 
 
The immune system consists of a collection of cells and soluble mediators to protect the 
host against microbial infections through two types of defense mechanisms, the innate and 
adaptive immunity. Innate immune response is mediated by pattern recognition receptors 
(PRR), and mediates blockage or elimination of infections in a rapid immune response. The 
innate immune system comprises of physical epithelial barriers, leukocytes such as 
neutrophils, monocytes, macrophages, dendritic cells (DCs), natural killer cells (NKCs), 
mast cells, eosinophils and basophils, as well as circulating plasma proteins such as 
complements. Adaptive immune responses are more specialized and mediated by antigen 
receptors that allow the generation of diverse antigen-presenting repertoire. T-lymphocytes 
and B-lymphocytes are players in adaptive immunity. The immune system’s ability to 
eliminate foreign microorganisms also suggests it has the potential to harm the body by 
reacting against harmless antigens or tissues from self. Such responses can cause allergy 
and autoimmune diseases. 
1.2 THE BASOPHIL CELL 
1.2.1 Basophil morphology and phenotype 
The basophilic granulocyte was discovered at the end of the nineteenth century by Paul 
Ehrlich, as blood-circulating cells that are 8-10 μm in diameter with a segmented and 
condensed nucleus, cytoplasm containing basophilic granules (Stone, Prussin and Metcalfe 
2010). They are very rare and represent less than 1% of peripheral blood leukocytes. 
Basophils are able to promote chronic allergy inflammation, to regulate T-helper2 (Th2) cell 
function and immune cell memory (Zhong et al. 2014, Voehringer 2013, Kawakami 2008) 
and even to perform as antigen-presenting cells (Kawakami 2008). Basophils express a 
variety of effector receptors e.g. cytokine, chemokine, complement receptors, prostaglandin 
receptors (CRTH2), cysteinyl leukotriene (LTD4, LTE4) receptors (Schroeder, Chichester 
and Bieneman 2009), immunoglobulin Fc receptors (FcεRI and FcγRIIb), and toll-like 
receptors (TLRs)(Sullivan and Locksley 2009). Many of them are beneficial in dissecting 
basophil function in inflammation.   
1.2.2  Basophil development  
Basophils arise from a common granulocyte-monocyte precursor (CD34+) in the bone   
marrow (BM). The granulocyte-monocyte precursors differentiate into mast cell precursors 
and basophil precursors. Mast cell precursors develop into mature mast cells and basophil 
precursors into basophils. The commitment of these precursors to the basophil lineage is 
dependent on the expression of the transcription factors GATA-2 and the CCATT enhancer-
binding protein C/EBP. They control the switching of the granulocyte-monocyte precursor to 
be differentiated into the basophil precursor or mast cell precursor, conferring to the 
upregulation and down regulation of GATA-2 and C/EBP. In basophil differentiation, C/EBP 
is upregulated to induce differentiation and maturation of basophils (Arinobu et al. 2005).   
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1.2.3  Basophil growth factors 
Basophils circulate in the blood stream and have a mature phenotype. The lifespan of 
basophils is fairly short (60–62h) (Ohnmacht and Voehringer 2009). Interleukine-3 (IL-3) is 
the main cytokine which promotes differentiation and subsequent survival of basophils in the 
BM. There are other growth factors regulating basophil formation and development in bone 
marrow such as interleukin-5 (IL-5) and the granulocyte-macrophage colony-stimulating 
factor (GM-CSF) (Hirai, Morita and Miyamoto 1992). 
1.3  BASOPHIL ACTIVATION 
Basophil activation is mediated by an array of signals including, antibodies (IgE, IgG), 
cytokines (IL-3, IL-18 and IL-33), proteases, TLRs ligands and complement factors (IgE-
independent pathway). When activated, basophils degranulate to release a variety of immune-
mediators such as histamine, proteoglycans (e.g. chondroitin and chondroitin sulphate), and 
proteolytic enzymes, which are pre-stored within cytoplasmic granules (Schroeder et al. 
2009). They also secrete lipid mediators such as leukotrienes and prostaglandins (LTC4, 
PGD2). Upon activation basophils produce several important cytokines (IL-3, IL-4, IL-6, IL-
13, IL-25), chemokines (RANTES, MIP-1α, MIP-1β, MCP-1) and GM-CSF (Schroeder et al. 
2009, Yamaguchi et al. 2009), chemotactic factors known to recruit multiple immune cells 
e.g. neutrophils toward the inflamed area (Figure 1). 
1.3.1 Antibody mediated basophil activation 
Basophils express the high-affinity receptors for Immunoglobulin-E IgE (FcεRI) and cross-
linking of FcεRI via IgE leads to rapid release of histamines and LTC4 from basophil 
granules, and production of cytokines. The rapid production of immune modulators links 
them as significant players during systemic anaphylaxis, which may occur when the allergen 
cross-links FcεRI-IgE on the basophil surface. Activation of basophils through FcεRI is 
known as the typical basophil activation pathway (IgE-dependent pathway) (Stone et al. 
2010, Steiner, Harrer and Himly 2016) but basophils can also be activated by 
Immunoglobulin-G IgG. They express IgG receptor (FcγRIIA) (activating receptor) and upon 
capture of IgG-allergen complexes, basophils release a platelet-activating factor (PAF), 
which increases vascular permeability and occasionally leads to anaphylaxis (Tsujimura et al. 
2008). In addition, basophils express another IgG receptor (FcγRIIB) (inhibitory receptor), 
which is coupled to the anti-inflammatory response of basophils.  
1.3.2  Toll Like Receptor (TLR) mediated basophil activation 
Basophils constitutively express mRNA of several Toll-like receptors (TLRs), including 
TLR2, TLR4, TLR9 and TLR10. TLR mRNA expression in basophils is generally less 
prominent than that in neutrophils and monocytes, but basophils express significantly higher 
levels of TLR2 and TLR4 mRNA (Komiya et al. 2006). TLR4 on basophils are involved in 
the pathogenesis of infection-induced exacerbation of allergic inflammation by modulating 
basophil functions.  
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1.3.3 Cytokine and chemokine mediated basophil activation 
Activated basophils secrete cytokines e.g. IL-4 which initiate the differentiation Th2 
lymphocyte and of IgE-secreting B-lymphocytes (Suurmond et al. 2014b). Accumulated 
evidence indicates that IL-3 is the most potent activator of basophils. Pretreatment of 
basophils with IL-3 results in marked enhancement of histamine release initiated by anti-IgE 
and formylmethionyl-leucyl- phenylalanine (fMLP) activation of basophils (Karasuyama et 
al. 2009). IL-3 signaling activation enhances basophil function by secretion of IL-4 and IL-13 
after IgE-dependent stimulation (Schroeder et al. 2009, Borriello et al. 2015a). IL-3 regulates 
the expression of activator markers in basophils such as the (CD203c) piecemeal 
degranulation marker (Sturm 2011, Gentinetta et al. 2011).  Basophils express IL-1 family 
receptors, IL-8 and IL-33 cytokine receptors and respond to IL-18 and IL-33; they are 
capable of activating basophil and augment Th2 responses (Kroeger, Sullivan and Locksley 
2009).  IL-33 is associated with IL-4, IL-13 and IgE production of basophils (Humphreys et 
al. 2008). Chemokines are also able to directly activate basophils. The most potent 
secretagogue chemokine inducing histamine release from basophils is MCP-1/CCL2 
(Schleimer et al. 1989).  
1.3.4 Protease mediated basophil activation 
Basophil activation is known to be mainly antibody- and cytokine-dependent, allergens and 
parasite-derived antigens are also capable of activating basophils directly. The antigens with 
protease activity activate basophils in an IgE-independent manner. Some allergens with an 
active protease antigen such as house dust mites (Dermatophagoides pteronyssinus 1) (Der p 
1) activate basophils and induce the production of IL-4 and IL-13 from basophils in the 
absence of antigen-specific IgE interaction (Phillips et al. 2003). In addition, papain, a 
cysteine protease allergen, can activate basophils and induce IL-4 and IL-6 production from 
murine basophils, as well as inducing the migration of basophils to lymph nodes (LNs) in 
vivo (Sokol et al. 2008). It has also been shown that helminth-derived proteases activate 
basophils with the same manner of allergen proteases. The underlying mechanism of protease 
basophil activation is not clearly known but it has been suggested that basophils express an 
unknown receptor recognized by proteases antigens (Chen et al. 2009).  
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Figure1. Basophil activation responses. Basophils express a variety of effector receptors and 
upon activation basophils secret effector mediators involved in the inflammatory responses. 
1.4 BASOPHIL DEGRANULATION  
Degranulation is a cellular process that releases immune mediators from secretory granules 
found in the cytoplasm of several cells involved in the immune responses, including 
granulocytes (neutrophils, basophils, and eosinophils) and mast cells (Kraft et al. 2005). 
There are two types of basophil degranulation: piecemeal degranulation (PMD) and 
anaphylactic degranulation (AND). During anaphylactic degranulation, the cells undergo 
rapid morphologic changes and exocytosis of intracellular granules, while in piecemeal 
degranulation cells secrete granule contents without exocytosis (Dvorak et al. 1983). 
1.4.1  IgE-dependent basophil degranulation 
The expression level of human basophil FcεR1 correlates with free IgE levels. FcεRI is a 
tetrameric (αβγ2) receptor where the extracellular domain of α subunit is the binding site of 
the Fc portion of IgE in basophil surface. Crosslinking of FcεRI by polyvalent antigens (i.e. 
allergens) or immune complexes recognized by bound IgE leads to aggregation of FcεRI-IgE 
in basophil surface, activation of downstream intracellular signaling cascade regulates 
calcium (ca+) mobilization in basophils, granule exocytosis, histamine release and cytokine 
production (Karasuyama et al. 2010).   
1.4.2  IgE-independent basophil degranulation 
Degranulation of basophils and histamine release can be induced by IgE-independent manner   
activation such as anaphylatoxins C3a and C5a, and the chemotactic tripeptide formyl-
methionyl-leucyl-phenylalanine (fMLP)(Chirumbolo et al. 2008).   
Formyl-methionyl-leucyl-phenylalanine (fMLP) is N-formyl peptides and they are the 
biologically relevant ligands for formyl peptide receptors (FPR) which are G protein-coupled 
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receptors. Basophils express the high affinity receptor FPR and its homologue formyl peptide 
receptor-like 1 (FPRL1), fMLP binds on basophils, that activates subsequent intracellular 
signaling pathways such as the MEK-ERK pathway and leads to chemotaxis and release of 
mediators such as leukotriene C4 (LTC 4) and histamine (Miura and MacGlashan 2000, de 
Paulis et al. 2004). 
Human basophils express complement-binding receptors e.g. CR3, CR4 and CD88 which is a 
receptor of C5a complement factor, and induce histamine release from basophils in an IgE-
independent manner (Schulman et al. 1988). 
1.4.3 Basophil expression of degranulation markers 
Basophil activation leads to upregulation of activator markers in basophil cell surface 
(CD203c and CD63) correlated to degranulation. As well as upregulation of the inhibitory 
marker which inhibits basophil degranulation (CD300a) (Figure 2). 
1.4.3.1   CD203c expression on basophils 
CD203c is an ectonucleotide pyrophosphatase/phosphodiesterase (ENPP)-3, CD203c has 
been known to be specific for basophils, mast cells and their progenitors (Buhring et al. 
1999). CD203c is expressed constitutively on resting basophils at low to intermediate levels 
and its expression is rapidly upregulated following activation of basophils. CD203c has been 
considered to be a piecemeal degranulation marker and its expression has been used as a 
marker to assess the basophil activity (MacGlashan 2010, Crivellato et al. 2003). 
1.4.3.2   CD63 expression on basophils 
CD63 is a membrane protein of the Lysosome-associated membrane glycoproteins (LAMP) 
family, a family of tetraspanin proteins often found to be involved in vesicle fusion. CD63 is 
located in the same granules as histamine and is often used as a marker of basophil activation 
and degranulation (Thyagarajan et al. 2012). 
1.4.3.3   CD300a expression on basophils 
CD300a is regarded as an inhibitory marker for degranulation. The inhibitory effect of 
CD300a in basophil degranulation is thought to arise from an Immuno Tyrosine Inhibitory 
Motif (ITIM) positioned within the intracellular domain of the receptor forming a reducing 
site for the inositol 5-phosphatase (SHIP). SHIP-1 is involved in reducing basophil responses 
following FcεRI activation However, CD300a is expressed with higher levels on IgE 
dependent basophil activation, while it is expressed with low levels in independent IgE 
activation (Gibbs et al. 2006, Gibbs et al. 2012). 
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Figure 2. Degranulation markers expression on basophils. Upregulation of CD203c, CD63 
and CD300a in activated basophils. 
 
1.5 BASOPHIL TRAFFICKING 
Basophils circulate predominantly in the blood, but they can also be found trafficking to 
lymph node (LN) and spleen. They are also recruited to sites of inflammation and involved in 
the inflammatory responses (Schmitz et al. 2005). Basophils express adhesion molecules and 
chemokine receptors which regulate cell transmigration (Figure 3). 
1.5.1 Basophil adhesion 
Basophil adhesion to vascular endothelial cells is regulated and enhanced by several 
cytokines such as IL-3, IL-5 and GM-CSF (Bochner et al. 1990, Yoshimura-Uchiyama et al. 
2003). Several receptors and mediators involved in basophil migration have been 
characterized. A family of adhesion receptors termed “selectins” (CD62L) is thought to 
mediate the initial attachment and rolling step; a number of chemotactic mediators have 
been implicated in the activation step, and integrins expressed on basophils binding to 
adhesion receptors (CD11b/CD18) belonging to the immunoglobulin superfamily are 
implicated in the firmer adhesion step. Enhancement of basophil adhesion by several 
cytokines is mediated by upregulation of surface β2 integrin (CD11b/CD18) expression.  
1.5.1.1   CD11b expression on basophils 
CD11b is an integrin family member which pairs with CD18 to form the CR3 heterodimer. 
CD11b is expressed on the surface of many leukocytes including monocytes, neutrophils, 
natural killer cells, macrophages and basophils. Functionally, CD11b regulates leukocyte 
adhesion and migration to mediate the inflammatory response. CD11b antibody studies have 
shown the protein to be directly involved in cellular adhesion, although migration can only 
take place in the presence of the CD18 subunit. It has been shown that the conformational 
changes in CD11b after activation may be more relevant to CD11b functional capacity than 
total cell surface expression. Conformational activation of CD11b exposes a neo-epitope 
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within the I domain known as CBRM1/5, and facilitates the actual binding capacity (Olsson 
et al. 2009, Kanayama et al. 2004). 
1.5.1.2   CD62L expression on basophils 
CD62L is an adhesion molecule involved in early leukocyte attachment to the endothelium at 
sites of inflammation and is rapidly shed after neutrophil and monocyte activation 
(Monteseirin et al. 2005, Xu et al. 2008). In a mice model study it was shown that basophils 
in systemic lupus erythematosus (SLE) upregulate CD62L (Charles et al. 2010). The 
cytoplasmic tail of CD62L has been reported to regulate shedding, microvillus positioning 
and the tethering/rolling mediated by interaction with at least three different proteins, 
including calmodulin, α-actinin (a member of the ezrin/radixin/moesin (ERM) family of 
membrane-cytoskeleton cross-linkers), and protein kinase C isoenzymes. Disruption of 
these interactions may reduce the shedding or inhibit tethering/rolling efficiencies (Jung 
and Dailey 1990, Dwir, Kansas and Alon 2001). 
1.5.2 Basophil transmigration  
Basophils expressed transcripts of various chemokine receptors such as CCR1, CCR2, CCR3, 
CCR5, CXCR1 and CXCR2 (Bischoff et al. 1992, Yamada et al. 1997). The most potent 
basophil migration is induced by eotaxin/CCL11. In addition, migration of basophils toward 
eotaxin was enhanced by very weak FcεRI-crosslinking activation. Basophil transmigration is 
regulated by several cytokines e.g. IL-3, GM-CSF, IL-5 and IL-4. Eotaxin binds specifically 
and exclusively to CCR3, whereas RANTES binds to CCR1 and CCR3, although with higher 
affinity for CCR1 both chemokines induced strong basophil Trans Endothelial Migration 
(TEM) (Iikura et al. 2004). Moreover, the chemokines IL-8 and RANTES induced basophil 
migration. Other chemokines, including MCP-1 displayed weak basophil attracting potency. 
In addition, studies suggest that matrix metalloproteinases (MMP-9) is expressed on the 
basophils, and enhances the expression of β2 integrin on basophils (Suzukawa et al. 2006).    
  
Figure 3. Basophil transferring process from blood circulation to inflammation area. 
Expression of adhesion molecules on basophils. 
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1.6  CHRONIC KIDNEY DISEASE AND BASOPHILS 
1.6.1 Definition and classification of chronic kidney disease (CKD) 
Chronic kidney disease is a worldwide public health problem, associated with progressive 
disturbance of the structure and function of the kidney tissue. Chronic kidney disease is 
linked to adverse outcomes of kidney failure, cardiovascular disease (CVD), and premature 
death (Levey et al. 2005). CKD is defined as kidney damage or glomerular filtration rate 
(GFR) <60 mL/min/1.73 m
2
 for 3 months or more, irrespective of cause. Kidney damage in 
many kidney diseases can be determined by the presence of albuminuria and 
albumin/creatinine ratio >30g/mol (Moe et al. 2006).  
CKD classification based on GFR level (Table 1): 
Stage 1 Kidney damage with normal or increased GFR ≥90 
Stage 2 Kidney damage with mildly decreased GFR 60 to 89 
Stage 3 Moderately decreased GFR 30 to 59 
Stage 4 
Severely decreased GFR 15 to 29 
Stage 5 
Kidney failure <15 or dialysis 
 
In patients with end stage renal disease (ESRD) treated with renal replacement therapy which 
includes dialysis, either hemodialysis (HD) or peritoneal dialysis (PD), and kidney 
transplantation. 
1.6.2  Dialysis therapy 
Dialysis is a procedure used to filter the blood wastes, fluids and salts that accumulate in the 
body due to kidney function failure. In peritoneal dialysis (PD) a peritoneal membrane lines 
the abdominal wall and works as a filter, and requires the placement of a catheter in the 
peritoneal cavity to allow fluid to be instilled and drained out. The filtration of wastes and 
excess water by PD procedure depends on different principles such as diffusion, osmosis, and 
ultrafiltration (Fenton et al. 1997). In hemodialysis (HD) the blood is circulated through an 
artificial kidney with two compartments: blood and dialysate, separated by a thin semi-
permeable membrane. Waste such as urea and excess water passes from the blood side to 
the dialysate side through a dialyzer membrane and is discarded into the drain. The cleaned 
blood is reverted to the patient, through insertion of access to the circulatory system such as 
arterio–venous fistula, arterio–venous graft, temporary catheter and long–term catheter 
(Ronco 2015). However, as a consequence of bio-incompatibility, blood-dialysis membrane 
contact may lead to a variety of adverse reactions in immune cells function and plasma 
proteins. 
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1.6.2.1   Hemodialysis and biocompatibility  
The biocompatibility is influenced by the interaction between the blood and the treatment 
materials. The surface material of the dialyzers and the membrane permeability properties 
are the main causes of alterations in leukocytes function, cytokine production, phagocytic 
efficiency, apoptosis, Radix Oxygen Species (ROS) production, and complement activation 
(Banche et al. 2006). The modified and synthetic materials were introduced to improve the 
biocompatible properties of the dialyzers. The permeability of the membrane contributes to 
the over-all biocompatibility properties. High flux dialyzers (with large pore size and higher 
ultrafiltration coefficients) cleared large molecules, such as  β2-microglobulin and toxins 
with enzymatic and metabolic inhibitory effect, compared to low flux dialyzers (with 
smaller pore size and lower ultrafiltration coefficients)(Chauveau et al. 2005), but the 
clinical consequences in terms of morbidity and mortality of long term use are still debated. 
1.6.2.2   Basophils and biocompatibility 
Hemodialysis patients may develop anaphylactic reactions. The underlying mechanism 
involved in hemodialysis-associated anaphylactic reaction can be related to IgE-mediated 
reaction due to cross linking of FcɛRI on the surface of basophils, and rapid release of 
histamine caused by sensitization by materials used during dialysis. Also non-IgE-mediated 
anaphylactic reaction may occur by accumulated C3a and C5a. Furthermore, the reaction 
might also be primed by accumulation of the potent vasodilator bradykinin, which induces 
histamine release from basophils (Ebo et al. 2006). During hemodialysis, IL-1β and TNFα 
cytokines are secreted from activated monocytes which induce histamine release from 
basophils (Subramanian and Bray 1987). 
1.6.3 Basophil function in CKD 
Involvement of basophils in autoimmune kidney diseases, such as lupus nephritis (LN), has 
previously been proposed. Formation of immune complexes may activate basophils to 
secrete IL-4, initiate Th2 differentiation, B cell proliferation, plasma cell differentiation and 
immunoglobulin production, and thereby be responsible for the ongoing humoral immune 
response in affected tissues. The auto-reactive immune complexes activate basophils and 
upregulate the cell surface expression of markers, such as CD203c and CD63 (Bosch et al. 
2011, Mack and Rosenkranz 2009). Circulating basophils have increased CD62L 
expression, which permits leukocyte homing to peripheral lymphoid tissues. Basophils also 
express the membrane-associated B-cell activating factor (BAFF), showing a potential role 
for lymph node basophils in B-cell survival and differentiation. In addition, basophils from 
mice lymph nodes and spleen have high expression of MHC II. Higher expression of MHC 
II and/or BAFF in the lymph nodes and spleen could permit communication with T and B 
cells (Charles et al. 2010). Activation of TLR pathways has been implicated in various renal 
diseases, including acute kidney injury, ischemia–reperfusion injury, allograft rejection and 
immune complex nephritis (Czyzyk 2006). The circulating immune complexes in 
autoimmune kidney disease bind to specific receptors on cell surfaces such as Fcγ receptors 
(FcγR) and TLRs activate cells (Gollapudi et al. 2010). TLR9 has been found to be 
expressed in the intracellular compartments of basophils and to be involved in the 
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activation of peripheral blood basophils in patients with systemic lupus erythematosus 
(Pellefigues and Charles 2013).  
1.7 ALLERGY AND BASOPHILS 
1.7.1  Allergic diseases  
Allergy is a worldwide medical problem; the prevalence of allergic diseases in westernized 
countries is 25-30% of the population (Pawankar et al. 2012). Allergy is a multifactorial 
disease resulting from the combination of genetic susceptibility and environmental factors. 
Allergic reactions vary in severity from mild itching to life threatening anaphylaxis. The 
broad spectrum and the potentially serious nature of symptoms negatively affect the quality 
of life for the affected individuals. Allergic diseases include food allergies, certain forms of 
asthma, rhinitis, conjunctivitis, angioedema, urticaria, and eczema, eosinophilic disorders, 
including eosinophilic esophagitis, drug and insect allergies (Pulendran and Artis 2012).  
1.7.2  IgE-mediated allergic response 
The IgE-mediated allergic response can be observed in two phases; sensitization phase and 
effector phase. The sensitization phase (formation of memory T cell, B cell and production 
of IgE antibodies of allergens) after uptake and processing the allergen by antigen 
presenting cells (APCs). The effector phase is divided into an acute response (5-15 minutes) 
which may be followed by a late reaction hours after allergen exposure (Larche, Akdis and 
Valenta 2006).  
1.7.2.1   Immediate allergic response and basophils 
Upon re-exposure to an allergen after the sensitization process, the immediate allergic 
reaction is initiated by allergen cross linking of IgE-ab bound to FcεRI on the basophil 
surface. Basophil activation is followed by degranulation and release of immune-
modulators such as histamine. Histamine causes symptoms depending on the site where 
sensitization and subsequent exposure have occurred. Together with newly produced 
cytokines (IL-4. IL-13) and chemokines, these mediators promote leukocyte recruitment to 
the site of inflammation and contribute to the late allergic response (He et al. 2013, Mukai 
et al. 2005).  
1.7.2.2   Delayed allergic response and basophils 
Delayed allergic reaction typically develops after 2–6 h of allergen exposure. It is usually 
preceded by acute allergic reactions and secretion of inflammatory mediators, which 
promote migration of cells e.g.TH2 cells, eosinophils, basophils and other leukocytes. This 
IgE-mediated reaction leads to aggregation of FcεRI, increased allergen uptake and 
recognition of allergen-derived peptides by specific memory CD4+T-cells, causing their 
reactivation and clonal expansion, which leads to aggravation of inflammatory responses. 
Delayed allergic reaction can occurs in the lungs in severe asthma, in the upper respiratory 
tract in individuals with allergic rhinitis and in the skin of individuals with atopic eczema. 
Promoted type 2 immune response enhances production of cytokines and leads to powerful 
late inflammatory response (Cromheecke, Nguyen and Huston 2014, Katz 1978) (Figure 4). 
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Figure 4. Schematic illustration of the role of basophils in IgE-mediated allergic reaction. 
  
1.7.3 Allergy diagnosis  
Clinical history and examination are the first-line of allergy diagnosis. The evaluation of a 
patient with suspected allergy starts with obtaining a systematic clinical history that reflects 
the indicative symptoms of allergic reactions. The clinical manifestations of allergy vary 
and correlate to entry site of allergen into the body and the onset of symptoms indicating 
the type of allergic reaction. However, the physical examination may indicate whether the 
reaction is acute or a chronic response. The clinical history and examination lack sufficient 
specificity and sensitivity to establish the diagnosis. Therefore, in vivo (skin testing) and in 
vitro (allergy-specific serum IgE-ab) investigations of sensitization are essential assistant 
tools for allergy diagnosis.  
1.7.3.1   In vivo testing 
Skin prick tests (SPTs) are a fast method of judging sensitization using mast-cell reactivity 
as a read-out for IgE-ab to suspected allergens. Commercially prepared allergen extracts 
can be used. SPTs are less expensive than in vitro testing. Skin testing can be safely 
performed in patients of any age; it causes the patient mild discomfort, and yields results 
within 15 minutes (Foong et al. 2016). Intradermal testing (ID) is another in vivo form of 
testing for allergens but is not recommended in the diagnosis, due to the high rate of false 
positive results, and the high risk of systemic life-threatening reactions (Bernstein et al. 
2008). Atopy patch tests (ATPs) involve the topical application of a solution containing 
allergens to the skin for 48 hours. However, ATP is not routinely recommended for example 
in patients with suspected food allergy (Nowak-Wegrzyn et al. 2008). Moreover, in vivo 
testing is contraindicated or ineffective in some cases (extended dermatitis, dermographism, 
severe atopic dermatitis, medication that inhibits cutaneous reactivity).  
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1.7.3.2   In vivo challenge tests  
The in vivo challenge test is mainly used for food allergy. Supervised food challenge 
controlled protocols where the suspected food allergens are introduced into the patient 
under a clinical observation. They are sometimes required for the absolute diagnosis of 
food allergy, in which a double-blind placebo-controlled food challenge (DBPCFC) is the 
most accurate form of challenge. Food is selected for testing based upon the history and the 
results of skin and/or in vitro testing (Sampson et al. 2012). Challenge tests can also be 
performed for airway allergic reaction (e.g. asthma) and nasal allergic rhinitis diagnosis 
(Charron and Pakhale 2016, Steveling et al. 2015). The challenge tests are time consuming, 
resource-intensive and run the risk of inducing systemic severe allergic reaction. 
1.7.3.3   In vitro testing 
Analysis of IgE-ab in serum is an important adjunct tool in the accurate identification of 
allergens. There are different detection systems for IgE-ab, e.g. HYTEC-288 
(HycorBiomedical), Immulite (Siemens) and ImmunoCAP (Phadia) (Boyce et al. 2011). 
The in vitro tests should be correlated with clinical history; higher amounts of IgE-ab are 
more likely to indicate clinical reactivity. However, the value of IgE-ab levels contrasts 
within wide ranges e.g. in food allergy age, time since last ingestion of suspected food, and 
other associated disorders affect the IgE-ab level (Sampson 2001). Both in vivo and in vitro 
testing detect sensitization, not clinical allergy; they cannot predict prognosis or severity of 
subsequent reactions. 
1.8 BASOPHIL FUNCTIONAL ANALYSIS 
1.8.1 Basophil analysis techniques 
Basophils play an important role at the crossroads of innate and acquired immunity. Despite 
their importance, research on basophils was hindered for a long time due to the rareness of 
basophils in peripheral blood which often resulted in scant yields and difficulty in their 
isolation. Moreover, only one genetically homogeneous human basophilic-like cell line, 
KU812 (Kishi 1985) is available. Furthermore, it has functional limitations including a 
variable cell surface expression of FcεRI and low grade of granulation (Jensen et al. 2005). 
This fact has led to the use of time-consuming and expensive methods for the purification 
of primary human basophils from whole blood or buffy coats having to be used, which has 
greatly limited in vitro studies of basophil biology. Given the recent advances in 
determining the biological role of basophils in mice using in vivo models, a technique that 
enables the generation of functional mouse basophils with a normal phenotype is vital. 
Several attempts have been made to develop basophil isolation and functional analysis but 
in most cases they have proved to be expensive and time-consuming approaches, such as 
bead-based isolation, immuno-selection of basophils by monoclonal antibodies and sorting 
by flow cytometry. 
1.8.2  Bead-based basophil functional analysis 
Bead-based cell isolation and analysis has been used for different cell fractions. 
Contaminated cells are able to secret the same cytokines or express the same surface 
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receptors as basophils and this interferes with the determination of these factors for 
basophils. Therefore, it is essential to obtain highly purified basophils for investigations 
where interference by other cells must be avoided. Several methods have been developed 
over time for the purification of the human basophil from blood and buffy coat in terms of 
purity, integral cell function and time of cell isolation, using both positive and negative 
isolation procedures (Gibbs et al. 1997, Gibbs, Papenfuss and Falcone 2008, Bjerke et al. 
1993). Cells isolated by beads undergo a gradient separation followed by a purification step 
with selective antibodies on magnetic beads. The isolated basophils have been used for the 
functional analysis and gene expression of basophils in many studies (Borriello et al. 
2015b, Abdullahi et al. 2016). 
 
1.8.3 Flow cytometry approach of basophil analysis 
 
In vitro studies of basophils obtained from peripheral blood include separation. Physical 
separation of basophil cells from whole blood or buffy coats can be done by immuno-
selection using monoclonal antibodies. Followed by basophils isolation by either a cell 
sorter (Yang et al. 2010) or electronically captured by a flow cytometer (Chirumbolo et al. 
2008). Flow cytometry can identify these cells and follow their response upon stimulation 
or inhibition; cells are captured as electronic events and plotted as a purified population in 
the so-called dot plot diagram. 
1.8.3.1   Flow cytometric basophil functional characterization 
 
Several phenotypic markers can be used to isolate basophils from other leukocytes. 
Basophils are typical CD45 cells in the lymphocyte area, express IL-3 receptor α-chain 
(CD123), and do not express HLA-DR and are used as a strategy for flow cytometric 
basophil gating. Many other strategies have been used to identify basophil biology e.g. 
(IgE+, CD3-/CRTH2+; CD3-/CCR3+; CD14-/CD13+, CD45+/CD203c+) (Chirumbolo, 
Ortolani and Vella 2011). When basophils have been gated, they can be analyzed for their 
response to several stimuli by detection of  upregulation or downregulation of different 
surface markers that correlate to different basophil functions such as CD63, CD203c, 
CD193 (CCR3), CD164, CD107a, CD62L, CD69 and CD11b (Florian et al. 2006, 
Hennersdorf et al. 2005, Komiya et al. 2006). Furthermore, flow cytometry can be used for 
the analysis of intracellular protein regulation after activation, such as signaling proteins or 
cytokines (Freer 2014, Verweij et al. 2010), by targeting them with fluorochrome 
conjugated antibodies. The flow cytometry assessment of basophil activation upon allergen 
challenge is the basic principle of the basophil activation test (BAT), a method capable of 
detecting antigen-dependent cellular response without any risk to the patient used in the 
allergy diagnosis (Wedi and Kapp 2010).  
 
1.8.3.2   Basophil activation test (BAT) 
 
The basophil activation test (BAT) is a flow cytometry based cellular assay that measures 
the activation of basophils upon allergen stimulation.  
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1.8.3.2.1   Technical characteristics of flow cytometry based BAT 
BAT can be used as a diagnostic technique to diagnose and monitor allergic patients. The 
activation response can be measured at a single cell level by using fluorochrome-bound 
monoclonal antibodies (mAbs) for specific activation markers. Currently, two activation 
markers, CD63 and CD203c, are commonly used for diagnostic purposes. Upon basophil 
activation, these two markers are upregulated, but they have different characteristics. CD63 
has been used as a degranulation marker upon anaphylactic stimulation (Abuaf et al. 2008). 
Although CD63 is also expressed on platelets, eosinophils, and monocytes, CD63 
expression on basophils can be identified using additional stains for basophil markers such 
as IgE, CD123, CCR3, CRTH2, and CD203c (Rouzaire et al. 2012). CD203c can also be 
used as an identification marker since it is exclusively expressed on basophils, and this 
expression is related to piecemeal degranulation of basophils (Hino et al. 2014). For the 
BAT procedure, fresh whole blood is withdrawn. Anti-FcεRI mAb, fMLP and anti-IgE are 
used as a positive control and stimulation buffer alone as a negative control. If subjects do 
not respond to a positive control (called non-responders), then their BAT results cannot be 
interpreted and have to be rejected in the analysis.  
1.8.3.2.2   Clinical application of BAT  
BAT is used as an ex vivo provocation test for allergy diagnosis.  It can be performed at the 
same time as sIgE, and in general precedes in vivo provocation tests, for example, oral 
food, drug, or bronchial challenge. It is clinically evaluated for the diagnosis of different 
allergy triggers e.g. inhalant allergy, food allergy and drug allergy. Furthermore, BAT has 
been used to monitor allergic patients under allergy immunotherapy (AIT) and anti-IgE 
treatment by measuring the change of basophil sensitivity related to allergen concentration 
by performing basophil allergen threshold sensitivity (CD-sens) (Hoffmann et al. 2015). 
Furthermore, BAT has been used to investigate basophil activation in autoimmune diseases 
such as lupus nephritis (LN) patients by measuring the change in CD203c and CD63 
expression in basophil surface after activation of FcεRI with autoreactive IgE complexes 
(Pellefigues and Charles 2013). Nevertheless, the cost and technical requirements for the 
operation and maintenance of flow cytometry and the long time for pre-processing and pre-
labeling of the sample before flow cytometric analysis have limited its reach for extended 
clinical application. 
1.9 MICROFLUIDIC BASED APPROACHES  
1.9.1  Introduction of microfluidics  
Microfluidics is a field of research that deals with behavior and manipulation of fluids, 
generally on the microliter to pico-liter scale, using channel dimensions constrained to 
hundreds of micro-meters. Microfluidics enables cellular and molecular studies by 
miniaturization of traditional macroscale methods to overcome several limitations of 
conventional bio-separation methods. Microfluidic technology reduces the required amounts 
of reagents, less waste, rapid analysis, high throughput, and less manufacturing cost 
(Whitesides 2006). From a biological point of view, microfluidics can partly reproduce the in 
vivo-like molecular and physical microenvironments of cells. Furthermore, microfluidic 
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systems allow the integration of many steps into a single chip to reduce the errors related to 
liquid handling or to obtain multiple data points from a single experiment. In general, in 
microfluidics, certain characteristics of the fluid flow become prominent, such as laminar 
flow. The fluid phenomena affect how microfluidic devices can be prepared and used 
(Dittrich, Tachikawa and Manz 2006, Ben-Ari et al. 2013, Dostovalov et al. 2011). 
1.9.2 Fluid dynamics 
In microfluidics where fluidic resistance and surface tension is dominant, the fluid flow is 
typically laminar, where viscous losses dominate over inertia losses, and mixing is based on 
diffusion. 
1.9.2.1   Reynold’s number  
The Reynold’s number (Re) is used to describe the fluid flow conditions. Re is a function of 
velocity and hydraulic diameter which depends on the channel’s cross-sectional geometry. Re 
<2300, indicates a laminar flow that is governed by Newton’s viscosity law (Yakhot 2014). 
In laminar flow fluid particles move along paths in thin layers in which one layer slides upon 
one another.  As Re approaches 2300, the fluid starts to show signs of turbulence, and as Re 
becomes greater than 2300 the flow is considered to be turbulent (Figeys and Pinto 2000, 
Yang and Li 1997). 
1.9.2.2   Laminar flow 
In microfluidics, Re is typically very small; in the order of 0.1. Laminar flow is a condition in 
which the velocity of a particle in a fluid stream is not a random function of time. In the 
micro-channels, the flow is almost always laminar (Pandey, Chaube and Tripathi 2015). In 
laminar flows, the fluid stream flows in parallel layers and mixing between the layers is based 
on diffusion. Diffusion between laminar streams has been used for sorting particles by size 
(Brody and Yager 1997, Hatch et al. 2001).  
1.9.2.3   Diffusion 
Diffusion is the movement of a concentrated group of particles in a volume over time so that 
the average concentration of particles in the volume is constant. Since distance varies in 
relation to the power square, diffusion becomes very important on the microscale. The 
diffusion time is small in the micro-channels; therefore, it can be used to generate a 
concentration gradient, which is used for a variety of biological assays (Jeon et al. 2000).  
1.9.2.4   Fluidic resistance 
The fluid resistance in the micro-channels is also one of the important factors affecting the 
fluid dynamic in a microfluidic chip. The flow rate within a microchannel is expressed as, 
where Qv is the flow rate, DP is the drop in pressure across the channel, and R is the channel 
resistance (Minucci et al. 2014). The fluid resistances in the micro-channels differ according 
to the geometry of the channels. 
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1.9.2.5   Surface tension  
Surface tension is an important force in the microscale. Surface tension is the result of 
consistency between liquid molecules at the liquid/gas interface. Micro-channels with 
dimensions on micro-meters are used; the lengths liquids will travel based on capillary forces 
alone are significant. Surface energies have been used in microfluidics by creating virtual 
walls (Zhao, Moore and Beebe 2001) as well as pumping. 
1.9.3 Microfluidic chip fabrication technologies 
Soft lithography is the most common method used for micro-fabrication of microfluidic 
devices. Briefly, a design is drawn using computer-aided design (CAD) software and printed 
at high resolution into a photomask which is a transparent sheet (Xia et al. 1999). The pattern 
is transferred to a substrate by photolithography. In photolithography, a substrate (the master) 
is coated with a photosensitive polymer layer and exposed to UV light through the 
photomask. During development, photoresist crosslinked to the substrate surface remains, 
while UN- crosslinked or cleaved photoresist areas are washed away. The standard 
photolithography has a resolution of approximately 1-2 μm, but there are other lithography 
methods used with higher resolution up to sub-100 nm such as E-beam, ion beam, and dip-
pen lithography. When using a negative photoresist, SU-8, the master substrate is ready to be 
used for molding. Alternatively, the pattern is transferred into the substrate material using a 
wet or dry etch process. Currently, the most common material used for fabricating 
microfluidic chips for biological applications is polydimethylsiloxane (PDMS), an elastomer 
that can be easily molded into microstructures and micro-channels. The mechanical and 
physical properties of PDMS are highly valuable for fabricating microfluidic chips. PDMS is 
transparent, biocompatible, and gas-permeable, which make it appropriate for molecular and 
cellular studies (Piruska et al. 2005, Belanger and Marois 2001). 
1.10 MICROFLUIDIC BASED CELL ISOLATION 
Microfluidics has been used for the isolation and analysis of a variety of cells.  Cells are 
isolated from a large population of other cell types based on one or several properties. 
Multiple separation techniques have been used to isolate the cells according to their physical 
properties such as cell size, deformability, compressibility, shape, density, size, surface 
properties; electrical polarizability, magnetic susceptibility and refractive index have been 
considered as biomarkers. In general, cell separation is categorized into two types: active and 
passive techniques. 
1.10.1   Active cell separation techniques 
As the name implies, active separation techniques require the addition of active forces to 
operate. External forces are used to utilize the particles’ properties for separation such as 
dielectric, optical, magnetic and acoustics separation.  
Briefly, dielectrophoresis (DEP) is an unlabeled technique (immuno-labeling of cells is not 
needed), which has been widely studied in microfluidics. DEP has been demonstrated to be 
capable of separating cells based on the variations in the dielectric properties of different 
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cell types. However this method is relatively slow, that affects the throughput of cell 
separation (Yang and Li 1997, Shamloo and Kamali 2017).  
Magnetophoresis is implemented by applying an external magnetic field and depends on 
the magnetic properties of different cells. This method has been used to isolate blood cells 
and sort macrophages from monocytes due to their dissimilar internalization rate of iron 
nanoparticles (Zhu et al. 2012). Magnetophoresis is often combined with immuno-labeling 
of cells with paramagnetic micro-and nanoparticles for continuous separation of cells.  
Optics has been used to manipulate cells. Recent advances in microfluidic techniques have 
led to the development of micro-cytometry. Cell sorting based on size (protein 
microcapsules) and refractive index (separating polymer from silica spheres) has been 
accomplished (MacDonald, Spalding and Dholakia 2003). Optical tweezer is a direct 
optical particle manipulation which uses focused beam of photons to trap particles in 
certain position (Li et al. 2016).  
Acoustophoresis is the application of ultrasonic sound waves to manipulate the particle 
positions. Different microfluidic devices can be used for cell separation using 
acoustophoresis e.g. silicon etched glass and glass capillary, acoustic separation and have a 
wide range of applications e.g. bead-based assay and bacteria separation (Ngamsom et al. 
2016) (Yin et al. 2017).  
1.10.2   Passive cell separation techniques 
Passive cell separation is a technique that requires no external forces for cell separation. 
Here, mechanical (size) based filtration or interaction with the fluid flow is used, such as in 
deterministic lateral displacement (DLD) and inertial microfluidics.    
Microfiltration technology is size-based passive separation that uses a variety of micro 
devices e.g. (pillar, wires), cross flow and hydrodynamic for particle filtration. Pillars and 
wires are mainly used for leukocyte separation from red blood cells (Zheng et al. 2007). 
The device consist of an inlet and main channel divided into sub-channels containing 
obstacles and outlets for leukocyte separation.  
Inertial microfluidics based separation, where the cell separation only relies on the size of 
the cells, requiring no immuno-staining or antibody. The flow rate, sample concentration, 
and device geometry are usually the key factors for the successful separation using this 
method. However, the overlap in physical properties of the target and non-target cells 
interferes with the separation purity (Yang, Leong and Sohn 2015, Ryu et al. 2017).  
Deterministic lateral displacement (DLD) is a technique, where the sample flows through an 
array of microposts where the array is arranged such that each row is slightly shifted. 
Particles with a size below a critical hydrodynamic diameter follow the periodic streamline 
patterns through the gaps, and are able to cross the posts Particles with a size above the 
critical hydrodynamic diameter cannot follow a streamline but bump against the posts, and 
are displaced laterally, opposite to the small particles (Huang et al. 2004).. Particles with 
different diameters can be separated and collected at different outlets. DLD has been used for 
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circulating tumor cell (CTC) separation (Liu et al. 2013). The DLD approach can effectively 
separate cells with different sizes, as well as cells with different shapes and deformability 
(Loutherback et al. 2012, Huang et al. 2004).   
1.10.3   Affinity-based approach 
Affinity-based cell separation approach is the most commonly used method to isolate target 
cells from a heterogeneous cell population, such as whole blood. Immunoaffinity is a 
classic cell isolation approach that uses an antibody as the affinity ligand to specifically 
retain one cell type with higher purity, while other cells are passed through the device. In 
immunoaffinity cell isolation, the microfluidic device is modified with an antibody specific 
to the target cells for isolation. Different subtypes of leukocytes have a unique combination 
of surface markers like CD3, CD4, CD8, CD18 etc, and can be targeted to specifically 
isolate cell subpopulations from whole blood. Microfluidic immunoaffinity based cell 
enrichment has been successfully performed to isolate (CD4+T cells) from HIV patients’ 
whole blood (Cheng et al. 2009, Wang et al. 2011). This technique has also been used for 
the isolation of rare cells from whole blood such as CTCs for the early detection of 
metastatic malignancies (Nagrath, et al. 2007, Deng, et al. 2014; Pratt, et al. 2011). The 
strong interaction between cells and a surface-bound affinity molecule is required for 
optimal capture efficiency. Therefore, the orientation of the immobilized antibody is an 
important factor for efficient antigen-antibody interaction for cell capture (Dong et al. 
2013). Another factor that should be considered in microfluidic immunoaffinity based 
capture approach is the change in the cell-antibody adhesion mechanics with the shear 
stress in the flow. Different cell types have different optimal shear stress standards for 
efficient capture. A Hele-Shaw device is normally used for analyzing and mapping of shear 
stress, where the unique geometry enables the shear stress to be decreased linearly over the 
length of the device (Usami et al. 1993) (Figure 5). The shear stress depends on the 
geometry of microfluidic channels and calculated by the formula below, where the flow 
rate of the fluid is optimized to maintain the target cell adhesion. Microfluidic chip design 
has been developed over time to improve cell capture efficiency, based on channel 
geometry and shear stress in micro-devices e.g. cancer cell capture devices (Stott et al. 
2010, Karabacak et al. 2014).  
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   Figure 5. Schematic illustration of a Hele-Shaw flow device.  The shear stress decreases 
linearly over the length of the device as a consequence of the increased cross-section area.    
   
1.11  MICROFUIDIC-BASED LAB-ON-CHIP FOR CELL BIOLOGICAL ANALYSIS  
Microfluidic technology has been used to study a variety of immune cell functions. 
Microfluidics has mostly been employed to investigate the cell migration and chemotaxis 
function of a broader range of cell types such as neutrophil and dendritic cells (DC). Some 
microfluidic devices have been developed for clinical applications. Neutrophils chemotaxis 
has been studied using chemoattractants such as (fMLP) and interleukin-8 (IL-8) where the 
cell morphology and migration responses were observed overtime in a microfluidic chip 
device (Wu et al. 2015). DC migration and trafficking in secondary lymphoid tissues is 
regulated by several chemokines, including CCL19 and CCL21, which have been employed 
in a flow-based microfluidic device to examine DC chemotaxis (Ricart et al. 2011). 
Moreover, Microfluidic technology has also been used to isolate neutrophil from whole 
blood for proteomics and genomic analysis (Kotz et al. 2010).  
1.11.1 Microfluidic based basophil functional analysis 
Recently, several microfluidic chip devices have been developed to study basophil function 
mainly related to allergic inflammatory responses, using basophil cell lines and bead-based 
basophil isolated cells. The basophil FcεRI activation pathway has been studied in an 
integrated microfluidic chip device. The Syk protein phosphorylation, calcium mobilization 
and the release of inflammatory mediators were monitored using cultured RBL-2H3 cells 
(Liu et al. 2013). Degranulation of allergen-treated basophil cell line KU812 cells has been 
studied using centrifugal microfluidics, using acridine orange (AO) fluorescent to stains the 
cell granules. Upon activation of cells by the stimuli, AO is released from the granules into 
the extracellular buffer through degranulation in a Ca2+-dependent manner. The drug 
screening to suppress the fMLP-mediated degranulation in basophils was recently 
 – Fluid viscosity 
Q – Vol. flow rate 
w – Channel width 
h – Channel height 
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examined using an integrated centrifugal microfluidic platform (Kwok et al. 2016, Chen et 
al. 2012). Furthermore, a chip-cytometry technique has been used for quantification of 
bead-based purified basophils from bronchoalveolar lavage (BAL) and blood in asthmatic 
patients(Dijkstra et al. 2014). 
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2 AIMS OF THE THESIS  
The general aim of the thesis is to investigate the role of the basophil in immune regulation in 
two inflammation driven diseases, chronic kidney disease and allergy. This is done by a 
newly developed microfluidic- based lab-on-chip technology together with the conventional 
methods.   
The respective aims of the four studies are: 
 Paper I. To study the consequence of different hemo-dialyzer membranes on basophil 
activation in chronic kidney disease (CKD) patients. 
Paper II. To study the basophil responsiveness towards different microbial antigens in CKD 
patients assessed by adhesion molecule expression and degranulation. 
Paper III. To develop a novel method, microfluidic immune-affinity Basophil Activation 
Test (miBAT), to study the regulation of degranulation markers on basophils in allergic 
patients. 
Paper IV. To assess the miBAT platform to be used as a reliable diagnostic method for 
allergy. 
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3 MATERIAL AND METHODS 
This chapter describes the study population (patients and healthy controls) and the methods 
used in the studies of the thesis. More detailed descriptions can be found in the material and 
methods of the respective four papers (I-IV). 
3.1 STUDY POPULATION 
3.1.1 Patient characteristics  
Study subjects from two different populations are included in this thesis. Patients in studies I 
and II were recruited from the Department of Nephrology at Karolinska University Hospital 
Solna, Stockholm, Sweden, and patients in studies III and IV were recruited from the Sachs’s 
Children and Youth Hospital, Stockholm, Sweden. Written informed consent was obtained 
from all participants and the local Ethics Committee in Stockholm, Sweden, approved all the 
studies. 
3.1.1.1   Study population in paper I 
The patients (n=10) had an estimated Glomerular Filtration Rate (eGFR) of <20 
ml/min/1.73 m2 (stage 5D) with a residual GFR from 6-11 (median 7). Patients were 
undergoing hemodialysis with polysulfone high flux dialyzers, effective surface area of 2.3 
m2, K0A urea: 1421 mL/min, ultrafiltration coefficient: 76 mL/h/mm Hg, three times per 
week for four to four and a half hours per dialysis before the study. The dialyzer membrane 
was shifted from a high-flux to a low-flux polysulfone capillary dialyzer (effective surface 
area of 1.8 m2, K0A urea: 976 mL/min, ultrafiltration coefficient: 14 mL/h/mm Hg).  An 
arteriovenous fistula or a central dialysis catheter was used for dialysis. 
Patients with cancer, an ongoing infection, chronic inflammatory disease and those taking 
immunosuppressive drugs were excluded. 
3.1.1.2   Study population in paper II 
Patients (n=10) with CKD stage 5D. The residual GFR ranged from 4-12 mL/min/1.73 m
2
 
(median 8.5). Patients were undergoing maintenance hemodialysis for four hours/session, 
three times per week, using polysulfone high-flux. 
Patients with cancer, an ongoing infection, chronic inflammatory disease and those taking 
immunosuppressive drugs were excluded. 
3.1.1.3   Study population in papers III and IV 
In paper III eight allergic patients were included in the study; they were allergic to different 
allergens. Patients were clinically diagnosed with asthma, rhinitis and conjunctivitis. In 
paper IV patients (n=7) allergic to at least one of the airborne allergens were recruited. 
Patients on oral steroids and Allergen-Specific Immuno Therapy (ASIT) were excluded.  
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3.1.2  Healthy controls 
In studies I and II the healthy controls (n=10) were recruited among healthy blood donors 
and were age and sex-matched (±5-7 years) with the patients. In studies III and IV healthy 
blood donors (n=7) were recruited from the Blood Center, Stockholm, Sweden. 
3.2 BASOPHIL CELL LINE (KU812) CULTURE 
Human basophil cell line (KU812) was used in paper III. Cells were cultured in RPMI1640 
media containing 10% FBS (Fetal bovine serum) and 0.2% non-essential amino acids 
(Sigma Aldrich, Germany). Cells were cultured in a CO2 incubator and the medium was 
renewed every two to three days through standard cell culture practice. 
 
3.3  METHODS OF BASOPHIL ANALYSIS 
 
3.3.1 Flow cytometric analysis of basophil 
3.3.1.1 Paper I 
Peripheral blood samples were collected in heparin tubes before and after dialysis process 
in each session (one occasion with a high-flux and one occasion with a low-flux dialyzer).  
3.3.1.1.1 Basophil activation analysis 
Basophil expression of degranulation markers (CD63 and CD203c) (Beckman Coulter) was 
analyzed by flow cytometry (Navios, Beckman Coulter), after activation of whole blood 
from patients and healthy controls with formyl-methionyl-leucyl-phenylalanine (fMLP) 
(Sigma Aldrich), and anti-Fcε receptor I (FcεRI) antibody (Bühlmann Laboratories).  
  
       
Figure 6. Basophil gating strategy (A) Basophils were gated according to their granularity 
on side scatter and expression of CD203c. (B) CD63 positive cells were detected within the 
total basophil population. 
A B 
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3.3.1.1.2 Basophil counting 
The absolute number of basophils was analyzed before and after dialysis sessions using the 
ImmunoPrep reagent system (Beckman Coulter), cell-counting beads (Flow-Count 
Fluorospheres, Beckman Coulter), and analyzed by flow cytometry (Navios).   
3.3.1.1.3 Adhesive markers analysis on neutrophils 
Surface expression of CD11b (Beckman Coulter) and active CD11b (Biolegand) on 
neutrophils was analyzed by flow cytometry (Navios), following treatment of whole blood 
with IL-8 (CXCL8) (Research & Diagnostics Systems). 
3.3.1.1.4 Expression of CD88 (C5aR) on neutrophils 
Whole blood was incubated with anti-CD88 antibody (Becton Dickinson), and expression 
of CD88 was detected by flow cytometry (Navios). 
 
3.3.1.2 Paper II 
Peripheral blood samples were drawn into heparin tubes from hemodialysis patients before 
the start of hemodialysis sessions. 
3.3.1.2.1 Adhesive markers expression on basophils 
Basophil expression of CD11b, active CD11b and CD62L (Becton Dickinson) was detected 
by flow cytometry (Navios), following activation of different basophil activation pathways 
using Lipopolysaccharide (LPS) (Sigma Aldrich, Germany), (fMLP), Peptidoglycan (PGN) 
(Sigma Aldrich, Germany) and anti-(FcεRI) antibody in blood from patients and healthy 
controls. 
3.3.1.2.2 Degranulation markers analysis on basophils 
Flow cytometric analysis of CD203c, CD63 and CD300a (Bio Rad) expression on basophil 
cell surface was done after activation of different basophil activation pathways (FcεRI, 
TLR and formyl-peptide receptor pathways).  
3.3.1.2.3 Expression of CD61 (platelet aggregation marker) on basophils 
The experiment was done to rule out the possibility that the change of CD63 expression 
was due to platelet aggregation and not basophil activation. Healthy whole blood was 
treated with anti-FcɛRI antibody; RPMI 1640 was used as negative control. CD63 and 
CD61 (MACS Miltenyi Biotech) expression on basophils was analyzed by flow cytometry 
(Navios).  
3.3.1.2.4 CD62L blocking on basophil surface  
The specificity of anti-CD62L binding in basophils was examined by the blocking of 
CD62L on the surface of basophils. Blood from healthy donor was incubated with (fMLP) 
and RPMI 1640 as a negative control. CD62L was blocked on basophil surface with un-
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conjugated anti-CD62L (Abcam) and cells subsequently stained with anti-CD62L PE-cy5 
(Becton Dickinson) and analyzed by flow cytometry (Navios). 
3.3.1.3 Papers III and IV 
3.3.1.3.1 Flow cytometric Basophil activation test 
In paper III, flow cytometry analysis of CD63 and CD203c (Beckman Coulter) expression 
was performed, after activation of whole blood from allergic and healthy individuals with 
anti-FcεRI (Bühlmann Laboratories). RPMI (Sigma Aldrich) was used as negative control. 
3.3.1.3.2 Flow cytometric analysis of basophil allergen threshold sensitivity 
In paper IV, the flow cytometry analysis of CD63 expression was performed after basophil 
activation with the relevant airborne allergen and non-relevant allergens concentrations 
1:10 dilution (5000, 500, 50 and 5 SQU/ml) (Aquagen, ALK, Copenhagen, Denmark). 
Anti-FcεRI was used as positive control and stimulation buffer as negative control. 
3.3.2  Immunocytochemistry of CD62L on basophils and neutrophils 
Immunocytochemistry technique was used in paper II. Whole blood was collected from a 
healthy donor and basophils were purified by MACS Basophil isolation kit (MACS, 
Miltenyi Biotec, Germany). Basophils were activated with fMLP and RPMI was used as 
negative control. Cells were fixed with paraformaldehyde (PFA) followed by incubation of 
the cells in blocking solution 1% bovine serum albumin (BSA). Cells were stained with 
primary unconjugated CD203c and CD62L then stained with secondary antibodies, stained 
basophils visualized by Eclipse Ti Nikon microscope. Images were transferred using 
MicroManager Version 1.4 software, plugged-in and processed using Imagej software. 
Neutrophils were activated with (fMLP) and stained with primary CD66b (MACS biotech) 
and anti-CD62L for microscopy imaging. 
3.3.3  Serological analysis of serum IgE antibodies 
In paper IV, sIgE level was analyzed in patients and healthy controls. Serum samples were 
sent to the diagnostic laboratory at the Karolinska University Laboratory. IgE-antibodies 
(IgE-ab) to allergens (timothy, birch, cat, dog, horse, mite and bee) were analysed using 
ImmunoCAP® (Thermo Fisher Scientific, Uppsala, Sweden), according to the 
manufacturer’s instructions. 
3.3.4 Microfluidic approach to basophil analysis 
In papers III and IV microfluidic chip technology was used for functional characterization 
of basophils regarding the expression of CD63 and CD203c and detected by fluorescent 
microscopy. Blood was collected from allergic patients and healthy controls. 
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 3.3.4.1 Chip microfabrication 
The microfluidic device was used in the experimental setup of papers III and IV and 
comprises a straight channel, where the width, height and length of the channel were 4 mm, 
50 µm and 25 mm respectively. A microfluidic device was fabricated in 
polydimethylsiloxane (PDMS) using standard soft lithography techniques (Xia et al. 1999). 
Briefly, channel replicas were produced on a silicon master by spin-coating, followed by 
UV exposure and developing to define the channel structures on the master substrate. The 
elastomeric PDMS (Dow Corning) was mixed with a cross-linker with a ratio of 
10:1(wt/wt), and poured onto the master and cured at 65°C. The curved PDMS with 
replicated channels was peeled off from the silicon wafer and the inlet and outlet holes were 
punched before the channels were bonded to a glass slide. 
3.3.4.2 Microfluidic chip surface modification 
The channels in the chip surface were modified, initially by 3-mercaptopropyl 
trimethoxysilane chemistry (Sigma Aldrich, Germany), followed by washing with ethanol 
and the addition of 4-Maleimidobutyric acid N-hydroxysuccinimide ester (GMBS) (Sigma 
Aldrich, Germany), a cross linking agent, then Neutravidin (Sigma Aldrich, Germany) was 
infused into the chips. Finally, biotinylated CD203c (MACS, Miltenyi Biotech, Germany), 
the antibody specific for basophils, was immobilized on the surface of the chips.  
3.3.5 Basophil capture characterization in microfluidic chip 
3.3.5.1 Basophil capture from basophil cell line (KU812) 
Straight channel capturing device was used to characterize basophil capture using basophil 
cell line (KU812) in paper III. The cells were washed and resuspended in 1xPBS for 
processing into the chip. 1% BSA (bovine serum albumin) (w/v) was pumped into the 
device surface at 20 µl min
-1
. 70 µl of the sample was pumped into the straight channel chip 
at chosen flow rates (1-20) µl min
-1
 using a syringe pump (Harvard apparatus, USA). The 
unbound cells were washed-out with 1% BSA at 20 µl min
-1
. Captured cells were stained 
using nuclear staining (Hoechst stain) (Sigma Aldrich, Germany), fluorescent images were 
taken by fluorescent microscope at different points all over the chips.  
3.3.5.2 Basophil capture from whole blood 
In paper III whole blood from healthy donors was processed into the capturing device at 
different flow rates (3-10) µl min
-1
, and the device was washed with 1% BSA at a flow rate 
of 20 µl min
-1
. The captured cells were stained using nuclear staining (Hoechst stain). In 
addition, CD203c was used to stain basophils in chips; fluorescent imaging of chips was 
done by fluorescent microscopy. Depletion assays were done by flow cytometry, basophil 
(CD203c) cells were counted in the aliquots collected before and after the passage of blood 
through the microfluidic device. The optimized flow rate was used for the subsequent 
experiments in papers III and IV (Figure 7). 
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Figure 7. Immunoaffinity basophil capture and activation of basophils in microfluidic chip. 
3.3.6  Basophil activation analysis in microfluidic chip 
3.3.6.1 Basophil activation in microfluidic chip with anti-FcɛRI antibody 
 In paper III, basophils captured in the chip were activated with anti-FcɛRI antibody 
(Bühlmann Laboratories) at 37
o
C. 1% BSA was pumped into the negative control chip. The 
captured cells in the chips were stained with CD63 and CD203c and expression of these 
markers was analyzed by fluorescent microscopy. The experiments were performed on 
blood from healthy donors and allergic patients. 
3.3.6.2 Basophil activation in microfluidic chip with airborne allergens 
In paper IV, captured basophils in chips were challenged with two concentrations (5000-50 
SQU/ml) of relevant airborne allergens (presence of IgE-ab) (birch, timothy, cat, dog or 
horse). A non-relevant allergen (absence of IgE-ab) (dust mite and bee) was used as control 
allergen. In addition a negative control (stimulation buffer) and a positive control (anti-
FcεRI antibody) were analyzed. CD203c and CD63 expression on captured basophils was 
thereafter detected by fluorescent microscopy. The experiments were performed on blood 
from healthy donors and allergic patients. 
3.4 STATISCAL ANALYSIS 
Statistical analysis in studies I-IV was done in GraphPad Prism 5 (GraphPad Software), 
Wilcoxon matched-pairs signed rank test for two dependent measurements (paper I), and 
Mann-Whitney U test for two independent sample groups (papers II, III, IV) was applied to 
analyze non-normally distributed values. For comparison of three independent measurements 
nonparametric Kruskal-Wallis test was carried out (papers I, II). 
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4 RESULTS AND DISCUSSION 
4.1  BASOPHIL ACTIVATION AND BIOCOMPATIBILITY EVALUATION IN 
HEMODIALYSIS (PAPER I)  
 
Hemodialysis is a process in which the accumulated uremic toxins, minerals and excessive 
fluid in end stage renal disease (ESRD) are removed from the blood by diffusion and 
filtration of the blood within the dialyzer. The interaction between blood and dialyzer 
membranes leads to alteration in immune cell function and circulating plasma proteins 
(Banche et al. 2006, Chauveau et al. 2005). The bioincompatibility of dialyzer membranes is 
dependent on the surface material and the membrane permeability (Craddock et al. 1977). In 
this paper, we hypothesized that the passage of basophils and neutrophils through the dialyzer 
affects basophil and neutrophil activation and that the effect on passing cells may differ 
between different pore sized dialyzers (high flux and low flux).  
Basophils were stimulated with fMLP and anti-FcεRI antibody, and basophil CD63 
expression was analyzed using flow cytometry. Venous blood samples were collected from 
CKD-patients before and after each session of dialysis using both dialyzers, and compared to 
blood collected from healthy controls. We observed that CD63 expression in fMLP-activated 
basophils in hemodialysis patients was significantly higher compared to healthy controls (p= 
0.04) (Figure 8A). However, this was not the case following stimulation with anti-FcεRI 
antibody.  
It is not clear whether the underlying mechanism of increased fMLP responsiveness is a 
consequence of altered fMLP receptor expression (formyl peptide receptor (FPR) or formyl 
peptide receptor-like 1 (FPRL1)), or whether the intracellular pathways (MEK–ERK 
pathway), involved in degranulation, are primed in basophils from CKD patients (Miura and 
MacGlashan 2000, de Paulis et al. 2004). Therefore, further analysis for better understanding 
of the underlying mechanisms involved in the increased fMLP responsiveness is needed.  
The CD63 expression on fMLP-activated basophils was significantly higher (p = 0.01) after 
dialysis with low-flux dialyzers compared with high-flux dialyzers. Anti-FcεRI antibody-
activated basophils’ CD63 expression was significantly increased (p = 0.002) after dialysis 
with both dialyzers (Figure 8B). In comparison between pre- and postdialysis in both 
dialyzers, CD63 expression was significantly higher on anti-FcεRI antibody-activated 
basophils following hemodialysis with low-flux membranes (P = 0.002) (Figure 8B). 
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Figure 8. Basophil activation (CD63 expression). (A) CD63 expression on basophils after fMLP and 
anti-FcεRI antibody comparing patients (pre dialysis) with healthy controls. (B) CD63 expression in 
activated basophils following dialysis with low-flux and high-flux dialyzers.  
The differences in FcεRI-mediated activation of basophils were detected following basophil 
passage through low flux polysulfone dialyzer but not through highflux dialyzer. Patients 
undergoing hemodialysis may develop anaphylactic reactions. The underlying mechanism 
involved in hemodialysis-associated anaphylactic reactions can be that the cross linking of 
FcɛRI on basophils results in a stronger response and release of immune-mediators such as 
histamine and heparin (Ebo et al. 2006). It has also been shown that different membrane 
surface charges can lead to activation of the Hageman factor and bradykinin which may 
activate basophils in an IgE-independent manner and induce histamine release followed by 
anaphylactic reactions during hemodialysis (Verresen et al. 1994). In this study, we suggest 
that the different pore size and ultrafiltration coefficient of the dialyzer membrane may have 
an impact on the priming of the basophils and their activation. This supports the notion that 
high-flux dialyzers may be favorable to have an advantage to low-flux dialyzers in this 
respect (Locatelli 2003, Eknoyan et al. 2002). Immune-mediators secreted from other cells 
during hemodialysis can also activate basophils, e.g. IL-1β has been shown to induce 
histamine release from basophils (Subramanian and Bray 1987). 
 Furthermore, the absolute number of basophils, before and after dialysis with either dialyzer, 
was unchanged compared to healthy controls. This indicates that the alteration of basophil 
A 
B 
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activation was due to functional variations and not to the entrapment of basophils in the 
dialyzer. 
CD11b and active CD11b (MAC-1) expression on neutrophils were analyzed. Active CD11b 
(MAC-1) is involved in neutrophil adhesion to endothelial cells, and transmigration toward 
the inflammation site. It has been shown that neutrophil CD11b expression increases during 
the hemodialysis procedure, using either low- or high-flux membranes. The transmigration 
process of neutrophils changes after dialysis by low-flux membranes (Moshfegh et al. 2002). 
In this study, we analyzed the surface expression of the CD11b active epitope on neutrophils.  
There were no significant differences in CD11b expression (MFI) on activated neutrophils 
when comparing dialysis patients with healthy controls and comparing both dialyzers. 
Moreover, we analyzed the expression of C5aR (CD88) on neutrophils. Anaphylatoxin C5a 
has been shown to be induced to various degrees by hemodialysis (Erlenkotter et al. 2008). 
C5a binds to C5aR and the interaction leads to cleavage of the receptor from the surface of 
the cells (Van den Berg et al. 2014), which indirectly indicates cell exposure to the 
anaphylatoxin. No significant differences were observed of CD88 expression on neutrophils 
either before or after hemodialysis. This could be due to the difference in the number of study 
subjects or the insensitivity of this molecule to assessment of bioincompatibility.  
In summary, in paper I we showed that basophil activation (CD63 expression) was 
significantly altered following low-flux hemodialysis and also in hemodialysis patients 
compared to healthy controls. In contrast, no difference was detected in CD11b and active 
epitope CD11b expression on neutrophils. This may suggest a role for the basophils as a new 
marker for evaluation of dialyzer membranes biocompatibility.  
4.2 BASOPHIL DYSFUNCTION IN CHRONIC KIDNEY DISEASE PATIENTS 
(STAGE 5D) (PAPER II) 
 
Patients with end stage renal disease (ESRD) on hemodialysis have a high risk of morbidity 
and mortality, which is mainly associated with cardiovascular disease and infections 
(Epstein 2015, Go et al. 2004). Basophils have been shown to have a potential role in 
immune function disturbances in CKD patients either due to retention of toxins or effect of 
hemodialysis (Vaziri et al. 2012, Bosch et al. 2011). In paper I we demonstrated that 
basophil responsiveness to bacterial peptide (fMLP) in hemodialysis patients is increased 
compared to healthy controls. Therefore, the aim of study II was to further investigate the 
potential basophil function alteration towards microbial antigen exposure, referred to 
adhesion molecule expression and degranulation in CKD patients on hemodialysis. For the 
transmigration process we selected the adhesion molecules CD11b, active epitope CD11b 
and CD62L and for the degranulation process CD203c (piecemeal degranulation marker), 
CD63 (degranulation marker), and CD300a (inhibitory marker of degranulation). We 
stimulated different basophil activation pathways, (TLR, Formyl-peptide receptor and 
FcεRI pathways).  
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Basophil expression of active CD11b (Mac-1) MFI was significantly increased (p=0.005) 
after LPS activation (TLR4) in patients compared to healthy controls. In contrast, there was 
no difference in the basophil expression of active CD11b epitope after TLR2 (PGN), fMLP 
or anti-FcεRI activation (Figure 9A).  
Previous studies reported that basophils have a relatively high expression of TLR-4 mRNA 
compared with the other TLRs (Suurmond et al. 2014a, Komiya et al. 2006). This 
corroborates our obtained data, which found that basophil responsiveness was higher after 
TLR4 activation than TLR2. Interestingly, basophils expressed significantly higher levels 
of active epitope CD11b which is more relevant to CD11b functional capacity; it is known 
that active epitope CD11b was formed due to a conformational activation of total CD11b 
on the cell surface, and facilitated the actual binding (Oxvig, Lu and Springer 1999, 
Arnaout 1990). This finding suggests that the basophils more readily adhere to endothelium 
and extravascular matrix after exposure to LPS. LPS-activated basophils secret pro-
inflammatory cytokines e.g. IL-1 and TNF-α, which may be involved in the inflammatory 
state in CKD patients (Suurmond et al. 2014a).  
An interesting finding was that the CD62L expression in basophils was stable after 
activation with LPS, PGN, fMLP and anti-FcεRI-ab. This was in contrast to the down-
regulation of CD62L MFI expression detected in activated neutrophils in hemodialysis 
patients. To examine the stability of CD62L, we performed a blocking experiment of 
CD62L in basophils (Figure 9B). Immunocytochemistry staining of CD62L in basophils 
and neutrophils before and after activation shows conserved expression of CD62L in 
basophils after stimulation compared with down-regulated CD62L in stimulated 
neutrophils. Moreover, CD62L was significantly down-regulated (p=0.04) after activation 
with anti FcєRI-ab in healthy controls, while, there was no significant difference in CD62L 
expression in comparison between patients and healthy controls. 
The CD62L expression in basophils is stable, in contrast to neutrophils and monocytes 
where it is rapidly shed from cell surface after activation (Monteseirin et al. 2005, Xu et al. 
2008). The cytoplasmic tail of CD62L interacts with at least three different proteins and 
disruption of these interactions may reduce the shedding, which may prohibit the rolling 
capacity in basophil (Jung and Dailey 1990, Dwir et al. 2001). We observed down-
regulation of CD62L in healthy controls after activation with anti-FcɛRI. A rationale for 
this observation is that stimulation with anti-FcɛRI enhances production of immune-
mediators such as TNF-α which modulates CD62L shedding (Thyagarajan et al. 2012).  
CD63 and CD300a expression in fMLP-activated basophils was significantly higher in 
hemodialysis patients compared to healthy controls (p=0.04 and p=0.01, respectively). 
Moreover, the expression of CD63 after activation with anti-FcɛRI antibody was not 
significantly different in patients compared to healthy controls, while the CD300a 
expression was significantly higher in patients (p=0.01) (Figure 9C). We observed that 
stimulation of TLRs in basophils did not upregulate CD63 expression in patients or in 
healthy controls. Furthermore, CD203c MFI and the ratio between CD63 and CD300a were 
not significantly different in patients. The expression of CD61 (platelet aggregation marker) 
was not significantly different in basophils after activation, indicating that the change of 
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CD63 regulation in basophils was due to basophil degranulation and not aggregation of 
platelet on the basophil surface.  
                 
       
  
Figure 9. Basophil expression of Active epitope CD11b, CD62L and CD300a (MFI). (A) 
Active epitope CD11b expression on basophils after stimulation of different pathways. (B) 
Flow cytometric analysis of CD62L on basophils and neutrophils. (C) CD300a expression 
in fMLP and anti-FcεRI-activated basophils.  
A 
B 
C 
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Activation of TLR did not upregulate CD63 in basophils. Previously, it has been shown that 
activation of basophil TLRs did not induce degranulation but did induce secretion of 
cytokines e.g. IL-4(Gyimesi et al. 2013). CD300a is an inhibitory marker for degranulation 
(Gibbs et al. 2006) and was significantly higher in patients as compared to healthy controls. 
The higher level of CD300a expression might indicate that the regulatory mechanism is in 
action as a response to increased CD63 expression.  
In summary, in paper II we showed that activation of basophil pathways related to exposure 
of microbial molecules, and significantly increased expression of the CD11b active epitope 
and the stability of CD62L expression, and this indicates that basophils in CKD patients 
have an impact on adhesion and transmigration. Moreover, upregulation of degranulation 
markers on basophils proposes an altered basophil degranulation process. Altogether, these 
results indicate the potential role of basophil in CKD patients. 
4.3 MICROFLUIDIC IMMUNOAFFINITY APPROACH - A NEW PLATFORM TO 
PERFORM BASOPHIL ACTIVATION TEST (PAPER III) 
 
IgE dependent basophil activation starts when an allergen cross-link IgE-ab is bound to 
FcєRI on the basophil surface (Stone et al. 2010). Activation of FcєRI enhances a number 
of downstream signaling events in the basophil leading to upregulation of intracellular Ca+ 
signaling which in turn induces cell degranulation, release of immune mediators, and 
upregulation of activator markers (CD63 and CD203c) on the basophil surface (Knol and 
Gibbs 2014). Detection and quantification of basophil activation markers can be done by 
flow cytometry. The flow cytometry based Basophil Activation Test (BAT) is used as a 
diagnostic tool for allergy but the complexity of the flow cytometry operation has limited 
use in the clinic. Therefore, the aim of paper III was to develop a novel method 
(microfluidic based immunoaffinity approach, miBAT) to perform a basophil activation 
test.  
The microfluidic chip was designed, modified and characterized to capture basophils 
directly from whole blood. The device was initially characterized using a basophil cell line 
(KU812), to optimize the capture and washing flow rates.  The optimal shear stress (flow 
rate) using the straight channel (50 µm x 4 mm height and width) corresponded to 3 µL 
min-1. When the shear stress was increased, the cell capture efficiency decreased. The 
decline in cells captured at a higher flow rate indicated less time for antibody-cell 
interaction. The cells can endure a washing rate of 20 µL min-1 and the maximum cell 
adhesion was at 10 mm along the length of the chip (Figure 10A). Moreover, the specificity 
of cell capture was confirmed using control chips (without anti-CD203c coating).  
Following the capture of basophil cell line in chips we moved on to capture basophils from 
whole blood. The highest basophil capture yield was at a flow rate of 3 µL min-1 and 
decreased gradually with higher flow rates.  The yield was analyzed by flow cytometric 
analysis of the basophil counts before and after the flow of blood through the chip (Figure 
10A). The capture purity, calculated as the ratio between the (CD203+ cells/total 
leukocyte), was approx. 40%. In a flow cytometry based basophil activation test the 
sufficient number of basophils is 200 (Sanz et al. 2002) and our device captured more than 
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this number. One ought to consider the impact of monocytes present due to their expression 
of a low level of FcεRI and CD63. However, the activation of the FcεRI pathway in 
monocytes is different and requires a higher concentration of stimuli and also longer 
incubation times to cross link FcεRI compared to basophils (Agis et al. 1996). Furthermore, 
captured basophils were also stained specifically with CD203c to exclude CD63 signals 
other than those from CD203c+cells.  
Further, the miBAT assay was evaluated to establish whether it was able to detect 
expression of activation markers on captured basophils. The captured basophils were 
stimulated by an anti-FcєRI antibody followed by staining and detection of CD203c and 
CD63 expression using fluorescence microscopy. We noticed that the CD203c mean 
fluorescence intensity (MFI) in captured activated basophils was significantly higher 
(p=0.02) than the non-activated basophils in healthy individuals and in allergic patients 
(p=0.04) (Figure 10B). The results were parallel to the flow cytometry analysis. CD203c 
can be considered to be both an identification and activation marker of piecemeal 
degranulation (PMD) for basophils. CD203c is expressed constitutively on basophils and 
upregulated upon activation.  
Expression of CD63 on anti-FcєRI-activated captured basophils was compared to non-
activated basophils in microfluidic chip. We found that CD63% in basophils from allergic 
patients (median and range) 48 (36-69) % was significantly higher (p=0.0002) compared to 
non-activated captured basophils (negative control) which was 22 (10-33) %. The same 
pattern was observed when basophils were analyzed by flow cytometry (p=0.0009).  
In microfluidic chip analysis we observed a relatively high basal in vitro value 
(background) in the negative control. The high background could be due to the presence of 
pyrogens and endotoxins that contaminated the materials such as plastic tubes or syringes 
used in the technique (Sanz et al. 2002). Therefore, it is important to work in a sterile 
environment and redesign a chip with the possibility of minimizing the assay process time 
that might reduce the negative background. The mechanical stress formed during the cell 
capturing process in the chip may prime the spontaneous activation of captured basophils 
and induce degranulation (Paszkowiak and Dardik 2003, Boccafoschi et al. 2010). The 
background was further analyzed by measuring the CD63 MFI of anti-FcεRI-activated 
basophils compared to non-activated captured basophils. The CD63 MFI was significantly 
higher (p=0.0001) in activated basophils than in non-activated captured cells, suggesting 
that the expression level of CD63 in activated basophils on a single cell level is higher than 
in non-activated cells (Figure 10C). The CD63MFI ratio (CD63MFI of activated 
basophils/CD63MFI in non-activated basophils) has previously been used to quantify 
basophil activation and to set the basophil activation threshold (Hoffmann et al. 2015). 
Moreover, the CD63 expression was significantly higher in anti-FcεRI activated captured 
basophils (p=0.03) in allergic patients compared to healthy controls. This result was parallel 
to the flow cytometry analysis of CD63 expression comparing both groups (p=0.04). This 
might be due to the variation of the FcɛRI expression level on basophils between allergic 
and non-allergic individuals, and may regulate the intensity of basophil degranulation and 
CD63 expression in basophils (Sihra et al. 1997). Furthermore, CD63 expression in 
activated captured basophils analyzed in microfluidic chips non-significantly differed 
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compared to flow cytometry analysis, indicating the sensitivity of miBAT technology to 
quantify basophil activation.  
 
                  
                                                                         
     
Figure 10. Basophil capture and activation markers expression (CD203c, CD63) in 
microfluidic chip. (A) Microfluidic chip characterization using basophil cell line (KU812) 
and whole blood. (B) CD203c expression in anti-FcεRI-activated basophils compared to 
non-activated basophils in microfluidic chip and flow cytometry. (C) CD63 expression in 
anti-FcεRI-activated basophils compared to non-activated basophils in microfluidic chip 
and flow cytometry, fluorescent image of activated basophil in chip, histograms of 
CD63MFI in activated captured basophils and non-activated basophils.   
A 
C 
B 
C 
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Altogether, the results presented in paper III show the ability of our miBAT technology to 
capture a sufficient number of basophils from whole blood, followed by detection of 
activation marker expression (CD203c, CD63) in anti-FcєRI-activated basophils. We also 
demonstrated that the data were comparable with flow cytometry analysis. 
4.4  MICROFLUIDIC BASED BASOPHIL ACTIVATION TEST FOR ALLERGY 
DIAGNOSIS (PAPER IV) 
 
Following the interesting results obtained by anti-FcєRI basophil stimulation in paper III, 
we further evaluated the microfluidic immunoaffinity BAT (miBAT) technique in paper IV 
for allergy diagnosis using allergens for activation. 
Basophils captured in the miBAT device were challenged with two concentrations of 
airborne allergens, anti- FcєRI (positive control), and stimulation buffer (negative control) 
in allergic and non-allergic individuals. 
We showed that CD63% expression in anti-FcεRI activated captured basophils was 
significantly higher (p=0.003) compared to CD63 expression in non-activated (negative 
control) basophils from allergic individuals. Moreover, CD63 expression on basophils from 
allergic patients was significantly higher after stimulation with the relevant allergen (5000 
and 50 SQU/ml) as compared to the negative control (p=0.01, p=0.003, respectively). The 
CD63 expression in basophils activated with a non-relevant allergen (control allergen) gave 
results comparable to the negative control (Figure 11A). Results obtained from the healthy 
controls showed that the CD63 expression of anti-FcεRI activated basophils significantly 
differed (p=0.005) from the negative control. In addition, allergen-treated basophils from 
healthy controls were not significantly different in comparison with negative controls. 
Despite the high negative background it is still possible to detect basophil activation in 
microfluidic chip.   
Flow cytometry analysis of CD63 expression in anti-FcεRI activated basophils from both 
allergic patients and healthy controls was significantly higher (p=0.0006, 0.004 
respectively) compared to non-activated basophils. Furthermore, flow cytometry analysis of 
CD63 in allergen-activated basophils compared to negative controls in allergic patients was 
significantly higher (p=0.006).  
Analysis of the CD63 mean fluorescence intensity (MFI) of allergen-activated basophils 
from allergic patients was significantly higher (p=0.0001) compared to non-activated 
captured basophils. This indicates that the level of CD63 expression in activated basophils 
on a single cell level is higher than in non-activated cells. This is in line with our previously 
obtained data regarding the CD63 MFI value in anti-FcεRI activated basophils. Therefore, 
the CD63MFI ratio (CD63MFI activated basophils/CD63MFI non-activated basophils) 
might be used to set the activation threshold to measure basophil activation.  
Furthermore, allergen-activated basophils using different concentrations from allergic 
patients showed comparable CD63 expression in microfluidic chip and flow cytometry 
(Figure 11B). We observed that the CD63 expression in allergen (5000 and 50 SQU/ml) 
activated basophils was significantly higher (p=0.003) in allergic patients as compared to 
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healthy controls. This was in line with the flow cytometry analysis data (p=0.001) 
(Figure11C).   
      
       
 
Figure 11. CD63 expression in allergen activated basophils. (A) CD63 expression in anti-
FcεRI and allergen-activated captured basophils compared to non-activated cells in 
allergic patients in microfluidic chip and flow cytometry. (B) CD63 expression in basophils 
after activation with different concentrations of allergen in microfluidic chip and flow 
cytometry. (C) CD63 expression in activated basophils from allergic and healthy 
individuals analyzed in microfluidic chip and flow cytometry. 
In summary, in paper IV we demonstrated that the miBAT technology was able to measure 
basophil activation after allergen exposure by quantifying their expression of CD63 in the 
microfluidic chip. The microfluidic chip discriminates between allergen activation and 
background as well as between stimulation with relevant and non-relevant allergens.  
  
A 
B 
C 
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5 CONCLUDING REMARKS AND FUTURE 
PERSPECTIVES 
 
The vital role of the basophil in the immune regulation of inflammatory diseases has been 
given less attention compared to other immune cells. The research on basophils was 
hampered for a long time due to the rareness of basophils in peripheral blood which often 
caused difficulty in isolating them. However, during the last decade basophils have been 
given some recognition mainly in allergic diseases (Karasuyama et al. 2009).  Basophils 
have also been shown to be involved in inflammatory responses of autoimmune kidney 
diseases, such as lupus nephritis (LN). Therefore, in the first part of this thesis, we 
addressed the question of whether basophil immune responses contributed to the 
inflammatory states of chronic kidney disease (ESRD) patients on hemodialysis, analyzed 
by conventional immunological methods.  
Our studies have demonstrated for the first time that blood-dialyzer interaction impacts the 
basophils responsiveness in CKD patients on hemodialysis and that anti-FcεRI and fMLP 
stimulation is affected when the cells pass through low- or high-flux polysulfone dialyzers. 
An increased responsiveness to fMLP in patients on hemodialysis compared to healthy 
controls was also observed, Taken together, these data suggest that basophil activation may 
be a new marker for evaluating dialyzer biocompatibility properties.   
In addition, we revealed that basophils in CKD patients (stage 5D) have an altered function 
judged by the regulation of transmigration and degranulation markers. A lack of CD62L 
shedding after basophil activation and upregulation of the CD11b active epitope in LPS-
activated basophils was observed. This notion together with an upregulation of CD300a and 
CD63 expression in fMLP-activated basophils indicates altered basophil transmigration and 
degranulation processes in CKD patients. These data propose a potential role for the 
basophil in the pathogenesis of complications related to infection in chronic kidney disease 
patients on hemodialysis.  
We reported that basophils contribute to inflammation and alteration mainly in innate 
immune responses in CKD patients on hemodialysis. However, the patho-physiological 
consequences of these observations warrant further studies. This is of importance for a 
deeper understanding of the underlying mechanisms of basophil functional alteration and 
the role of basophils in the state of immune deficiency in CKD patients that leads to severe 
complications e.g. recurrent infections, which can lead to further deterioration of the 
patient’s condition and disease progression.  
The techniques that are currently used for the purification of primary human basophils from 
whole blood or buffy coats are time-consuming and complex methods, which have greatly 
constrained in vitro studies of basophil biology. Therefore, in the second part of the thesis, 
we aimed to develop a novel microfluidic based method to isolate basophils directly from 
whole blood in a single step. The cells were thereafter subjected to analysis of the 
regulation of a degranulation marker in activated basophils in allergic patients and, in 
parallel, compared to flow cytometry analysis. 
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We developed a microfluidic based basophil activation test (miBAT), capable of isolating 
basophils from whole blood and detecting the activation markers’ expression (CD203c and 
CD63) in anti-FcεRI activated captured basophils. We compared samples from both allergic 
patients and healthy controls. The miBAT results were comparable to flow cytometry data, 
which indicates the efficacy of our system to measure the basophil activation level by 
quantification of CD203c and CD63 expression in anti-FcεRI activated captured basophils. 
The flow cytometry-based basophil activation test is a method used in allergy diagnosis and 
monitoring. However, the complexity of the flow cytometry technique has limited its use in 
the clinic and we therefore presented the miBAT technology as a potential method to be 
used as a point of care for allergy diagnosis. Our study demonstrated that miBAT 
technology is able to detect the difference in degranulation marker expression (CD63%) in 
allergen-activated captured basophils compared to non-activated basophils in allergic 
patients. Moreover, increased CD63 expression in allergen-activated basophils in allergic 
patients compared to healthy controls was detected using miBAT. Overall, the results 
obtained using microfluidic chip analyses were comparable to flow cytometry analysis. 
Altogether, these data verified the efficacy of our device to be used to measure the level of 
basophils activation by quantifying their expression of CD63 in the microfluidic chip in 
allergic patients. The simplicity of this technique provides a new and consistent method to 
perform BAT using a microfluidic chip, which enables diagnosis and monitoring of allergic 
patients.  
MiBAT is an interesting technology and, with further technical development, which shows 
great potential to be used for the clinical diagnosis of allergy or the monitoring of patients 
under treatment. Furthermore, the microfluidic chip represents valuable technology that can 
be employed in several applications either clinically or when studying biological cell 
functions 
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